Private equity giant KKR to buy Japan's Bushu Pharmaceuticals

Private equity giant KKR & Co Inc announced Tuesday that it would buy Japanese drug developer Bushu Pharmaceuticals, which is based in Hong Kong. However, the details of the acquisition were not disclosed.